References
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
- Susanne SC, Ito K, Raoof M, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330–379. doi: 10.1067/j.cpsurg.2018.08.004.
- Riihimäki M, Hemminki A, Sundquist J, et al. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765. doi: 10.1038/srep29765.
- Ito K, Govindarajan A, Ito H, et al. Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J. 2010;16(2):103–110. doi: 10.1097/PPO.0b013e3181d7e8e5.
- Engstrand J, Nilsson H, Strömberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78–89. doi: 10.1186/s12885-017-3925-x.
- Birrer DL, Tschuor C, Reiner CS, et al. Multimodal treatment strategies for colorectal. Swiss Med Wkly. 2021;151:w20390. doi: 10.4414/smw.2021.20390.
- Petrelli F, Comito T, Barni S, et al. Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review. Radiother Oncol. 2018;129(3):427–434. doi: 10.1016/j.radonc.2018.06.035.
- Lee J, Shin I-S, Yoon WS, et al. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review. Radiother Oncol. 2020;145:63–70. doi: 10.1016/j.radonc.2019.12.004.
- Lam-Boer J ,Al Ali C, Verhoeven RH, et al. Large variation in the utilization of liver resections in stage IV colorectal cancer patients with metastases confined to the liver. Eur J Surg Oncol. 2015;41(9):1217–1225.
- Pawlik TM, Abdalla EK, Ellis LM, et al. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006;10(2):240–248. doi: 10.1016/j.gassur.2005.07.027.
- Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–1137. doi: 10.1056/NEJMsa012337.
- Ho V, Heslin MJ, Yun H, et al. Trends in hospital and surgeon volume and operative mortality for cancer surgery. Ann Surg Oncol. 2006;13(6):851–858. doi: 10.1245/ASO.2006.07.021.
- Stitzenberg KB, Meropol NJ. Trends in centralization of cancer surgery. Ann Surg Oncol. 2010; 17(11):2824–2831. doi: 10.1245/s10434-010-1159-0.
- Torzilli G, Viganò L, Giuliante F, et al. Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it. Updates Surg. 2016;68(2):135–142. doi: 10.1007/s13304-016-0373-0.
- Vallance AE, VanderMeulen J, Kuryba A, et al. Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases. Br J Surg. 2017;104(7):918–925. doi: 10.1002/bjs.10501.
- Weledji EP. Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer. Oncol Rev. 2017;11(2):331. doi: 10.4081/oncol.2017.331.
- Huguet M. Centralization of care in high volume hospitals and inequalities in access to care. Social Science & Medicine. 2020;260:113177. doi: 10.1016/j.socscimed.2020.113177.
- Cadilhac DA, Moodie ML, Lalor EE, et al. Improving access to evidence-based acute stroke services: development and evaluation of a health system model to address equity of access issues. Aust Health Review. 2006;30(1):109–118. doi: 10.1071/AH060109.
- Addicott R, McGivern G, Ferlie E. The distortion of a managerial technique? The case of clinical networks in UK health care. Br J Management. 2007;18(1):93–105. doi: 10.1111/j.1467-8551.2006.00494.x.
- Balkundi P, Harrison DA. Ties, leaders, and time in teams: strong inference about network structure’s effects on team viability and performance. AMJ. 2006;49(1):49–68. doi: 10.5465/amj.2006.20785500.
- Inkpen AC, Tsang EWK. Social capital, networks, and knowledge transfer. AMR. 2005;30(1):146–165. doi: 10.5465/amr.2005.15281445.
- Koka BR, Prescott JE. Strategic alliances as social capital: a multidimensional view. Strat Mgmt J. 2002;23(9):795–816. doi: 10.1002/smj.252.
- Nolte E, Pitchforth E, Miani C. The changing hospital landscape: an exploration of international experiences. RAND Health Quarterly. 2014;4(3):14–20.
- Van de Voorde C, Van den Heede K, Beguin C, et al. Required hospital capacity in 2025 and criteria for rationalisation of complex cancer surgery, radiotherapy and maternity services. Brussels: Federatie Kennisgeving voor de Gezondheidszorg; 2017.
- Netherlands Comprehensive Cancer Organisation, Citrienprogramma Naar regionale oncologienetwerken, Dutch Federation of Cancer Patient Organisations & SONCOS Federation of Medical Specialists, on behalf of Taskforce Oncologie. Regionale Oncologienetwerken in Beeld [Internet]. 2022 [cited 2023 Apr]. Available from: https://oncologienetwerken.nl/sites/default/files/2022-04/Rapport_Oncologienetwerken-in-beeld_2022-april_1.pdf
- Kelaher M, Sabanovic H, La Brooy C, et al. Does more equitable governance lead to more equitable health care? A case study based on the implementation of health reform in aboriginal health Australia. Soc Sci Med. 2014;123:278–286. doi: 10.1016/j.socscimed.2014.07.032.
- Bambra C, Garthwaite K, Hunter D. All things being equal: does it matter for equity how you organize and pay for health care? A review of the international evidence. Int J Health Serv. 2014;44(3):457–477. doi: 10.2190/HS.44.3.c.
- Kroneman M, Boerma W, van den Berg M, et al. The Netherlands health system review. 2nd ed. Health Syst Trans. 2016;18:1–240.
- Foundation For Oncological Cooperation (SONCOS). Multidisciplinary standards for oncological are in the Netherlands. 2021.
- Nederlandse Vereniging voor Heelkunde (NVvH). Normering Chirurgische Behandeling v1.0. 2011.
- Kolfschoten NE, Marang van de Mheen PJ, Gooiker GA, et al. Variation in case-mix between hospitals treating colorectal cancer patients in The Netherlands. Eur J Surg Oncol. 2011;37(11):956–963. doi: 10.1016/j.ejso.2011.08.137.
- Oncologisch Netwerk Zuidoost-Nederland. OncoZON [Internet]. 2017 [updated 2020 Dec 3]. Available from. https://www.oncozon.nl/.
- Netherlands Comprehensive Cancer Organisation (IKNL). Netherlands Cancer. Registry (NCR). Available from https://iknl.nl/en/ncr.
- Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology (ICD-O). 3rd ed. 1st revision. Geneva: World Health Organisation. [Internet]. 2013. Available from: https://apps.who.int/iris/handle/10665/42344
- Sobin LH, Gospodarowicz MK, Wittekind CH, Union for International Cancer Control (UICC). The TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell; 2009.
- Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;53(3):983–997. doi: 10.2307/2533558.
- G KM, H RJ. An improved approximation to the precision of fixed effects from restricted maximum likelihood. Computat Statist Data Anal. 2009;53:2583–2595.
- Tiernan J, Briggs CD, Irving GRB, et al. Evaluation of the introduction of a standardised protocol for the staging and follow-up of colorectal cancer on resection rates for liver metastases. Ann R Coll Surg Engl. 2010;92(3):225–230. doi: 10.1308/003588410X12628812458419.
- Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, et al. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in The Netherlands: a population-based study. Lancet Gastroenterol Hepatol. 2022;7(1):60–68. doi: 10.1016/S2468-1253(21)00368-X.
- Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750–751. doi: 10.1016/S1470-2045(20)30265-5.
- Fields AC, Lu PW, Yoo J, et al. Treatment of stage I-III rectal cancer: who is refusing surgery? J Surg Oncol. 2020;121(6):990–1000. doi: 10.1002/jso.25873.
- Rahouma M, Harrison S, Kamel M, et al. Consequences of refusing surgery for esophageal cancer: a national cancer database analysis. Ann Thorac Surg. 2018;106(5):1476–1483. doi: 10.1016/j.athoracsur.2018.06.030.
- Coffman A, Torgeson A, Lloyd SC. Correlates of refusal of surgery in the treatment of non-metastatic pancreatic adenocarcinoma. Ann Surg Oncol. 2019;26(1):98–108. doi: 10.1245/s10434-018-6708-y.
- Pines JM, Strong A. Cognitive biases in emergency physicians: a pilot study. J Emerg Med. 2019;57(2):168–172. doi: 10.1016/j.jemermed.2019.03.048.
- Kongstvedt PR. Essentials of managed health care. (4th edition). Sudbury, Massachusetts: Jones and Bartlett Publishers; 2000. (Chapter 19: physician Behavior Change in Managed Health Care).
- Davis R, Campbell R, Hildon Z, et al. Theories of behaviour and behaviour change across the social and behavioural sciences: a scoping review. Health Psychol Rev. 2015;9(3):323–344. doi: 10.1080/17437199.2014.941722.
- Reinertsen JL. Algorithms, guidelines, and protocols: can they really improve what we do? Transfusion. 1994;34(4):281–282. doi: 10.1046/j.1537-2995.1994.34494233573.x.
- Henderson J, Valenti LA, Britt HC, et al. Estimating non-billable time in Australian general practice. Med J Aust. 2016;205(2):79–83. doi: 10.5694/mja16.00287.
- Gebhardt B, Rajagopalan M, Gill B, et al. Impact of dynamic changes to a bone metastases pathway in a large, integrated, national cancer institute-designated comprehensive cancer center network. Pract Radiat Oncol. 2015;5(6):398–405. doi: 10.1016/j.prro.2015.06.013.
- Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–1465. doi: 10.1001/jama.282.15.1458.
- Mekenkamp LJM, Koopman M, Teerenstra S, et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer. 2010;103(2):159–164. doi: 10.1038/sj.bjc.6605737.
- Punt CJA, Swijnenburg RJ, van Grieken NCT, et al. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases CAIRO5 a randomised phase 3 study of the Dutch Colorectal Cancer Group (DCCG) – study protocol v12 [Study protocol]. 2022 Feb 17. Available from: https://dccg.nl/trial/cairo5
- Wang M, Dolovich L, Holbrook A, et al. Factors that influence community hospital involvement in clinical trials: a qualitative discriptive study. J Eval Clin Pract. 2022;28(1):79–85. doi: 10.1111/jep.13583.